Economic evaluation of a Decision Support Tool to guide intensity of mental health care in general practice: the Link-me pragmatic randomised controlled trial

Table 4 Incremental cost-effectiveness ratios using ITT data (imputed) and based on unadjusted cost differences

	All participants	Minimal/mild prognostic group	Severe prognostic group
	n = 1671	n = 830	n = 841
Health sector perspective
ICER (95% CI)
6 months	$1,082/point improvement on K10	Dominated	$860/point improvement on K10
6 months	(391 to 6,204)	(81 to Dominated)	(366 to 2320)
12 months	$2,371/point improvement on K10	Dominated	$1,326/point improvement on K10
12 months	(191 to Dominated)	(712 to Dominated)	(28 to 8361)
Societal perspective
ICER (95% CI)
6 months	$1,257/point improvement on K10	$133/point improvement on K10	$776/point improvement on K10
6 months	(Dominant to Dominated)	(Dominant to Dominated)	(82 to 2551)
12 months	$1,217/point improvement on K10	Dominated	$479/point improvement on K10
12 months	(Dominant to Dominated)	(4444 to Dominated)	(Dominant to 8539)

CI Confidence interval, ICER Incremental cost-effectiveness ratio, Dominated Greater costs and less benefit than the comparator, Dominant Less costs and greater benefits than the comparator. ICERs and CIs were estimated based on 1,000 bootstrap samples of the multiply imputed data

ISSN: 2731-4553